Esmolol patient counseling information: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Ahmed Zaghw (talk | contribs)
nocaptcha
4,404 edits
No edit summary
Alonso Alvarado (talk | contribs)
nocaptcha
2,960 edits
 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Esmolol#Patient Counseling Information]]
{{Esmolol}}
{{CMG}}; {{AE}} {{AZ}}
 
==Patient Counseling Information==
 
Physicians should inform patients of the risks associated with BREVIBLOC injection:
 
The most common adverse reactions are :
 
:*Symptomatic [[hypotension]] (hyperhidrosis, dizziness):*Asymptomatic hypotension.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher =  | date =  | accessdate = }}</ref>
==References==
{{Reflist}}
 
{{FDA}}


[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]

Latest revision as of 19:52, 21 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Esmolol_patient_counseling_information&oldid=997181"